These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27695921)

  • 1. Sex differences and the role of dopamine receptors in the reward-enhancing effects of nicotine and bupropion.
    Barrett ST; Geary TN; Steiner AN; Bevins RA
    Psychopharmacology (Berl); 2017 Jan; 234(2):187-198. PubMed ID: 27695921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats.
    Palmatier MI; Levin ME; Mays KL; Donny EC; Caggiula AR; Sved AF
    Psychopharmacology (Berl); 2009 Dec; 207(3):381-90. PubMed ID: 19760281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A behavioral economic analysis of the value-enhancing effects of nicotine and varenicline and the role of nicotinic acetylcholine receptors in male and female rats.
    Barrett ST; Geary TN; Steiner AN; Bevins RA
    Behav Pharmacol; 2018 Sep; 29(6):493-502. PubMed ID: 29634495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT(2C) receptor agonist but not by a 5-HT(2A) receptor antagonist.
    Guy EG; Fletcher PJ
    Pharmacol Biochem Behav; 2014 Oct; 125():40-47. PubMed ID: 25158104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences in the Reward-Enhancing Effects of Nicotine on Ethanol Reinforcement: A Reinforcer Demand Analysis.
    Barrett ST; Thompson BM; Emory JR; Larsen CE; Pittenger ST; Harris EN; Bevins RA
    Nicotine Tob Res; 2020 Feb; 22(2):238-247. PubMed ID: 30982885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased sensitivity to the effects of dopamine D1-like, but not D2-like, receptor antagonism in the posterior hypothalamic region/anterior ventral tegmental area on brain reward function during chronic exposure to nicotine in rats.
    Bruijnzeel AW; Markou A
    Brain Res; 2005 Oct; 1058(1-2):91-100. PubMed ID: 16126181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats.
    Terry P; Katz JL
    Psychopharmacology (Berl); 1997 Nov; 134(2):201-12. PubMed ID: 9399385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of bupropion substitution for the interoceptive stimulus effects of nicotine.
    Wilkinson JL; Carroll FI; Bevins RA
    J Psychopharmacol; 2010 Jun; 24(6):817-28. PubMed ID: 19304864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC; Miller JR; Dohrmann JM; Caine SB
    Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats.
    Harrison AA; Gasparini F; Markou A
    Psychopharmacology (Berl); 2002 Feb; 160(1):56-66. PubMed ID: 11862374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats.
    Bruijnzeel AW; Markou A
    Synapse; 2003 Oct; 50(1):20-8. PubMed ID: 12872290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate-dependent effects of bupropion on nicotine self-administration and food-maintained responding in rats.
    Stairs DJ; Dworkin SI
    Pharmacol Biochem Behav; 2008 Oct; 90(4):701-11. PubMed ID: 18602678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell.
    Paterson NE; Balfour DJ; Markou A
    Eur J Neurosci; 2007 May; 25(10):3099-108. PubMed ID: 17561823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.
    Paterson NE; Balfour DJ; Markou A
    Nicotine Tob Res; 2008 Jun; 10(6):995-1008. PubMed ID: 18584463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of D1 and D2 receptors in the cocaine conditioned place preference of male and female rats.
    Nazarian A; Russo SJ; Festa ED; Kraish M; Quinones-Jenab V
    Brain Res Bull; 2004 May; 63(4):295-9. PubMed ID: 15196654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing roles for dopamine D1- and D2-like receptors in discrete cue-induced reinstatement of food seeking.
    Ball KT; Combs TA; Beyer DN
    Behav Brain Res; 2011 Sep; 222(2):390-3. PubMed ID: 21497172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decrease operant responding for nicotine and food and locomotor activity in male and female rats.
    Chellian R; Behnood-Rod A; Wilson R; Lin K; Wing-Yan King G; Bruijnzeel AW
    J Psychopharmacol; 2023 Feb; 37(2):216-228. PubMed ID: 36680471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic and dopamine D2 receptors mediate nicotine-induced changes in ventral tegmental area neurotensin system.
    Alburges ME; Hoonakker AJ; Hanson GR
    Eur J Pharmacol; 2007 Nov; 573(1-3):124-32. PubMed ID: 17689525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of risk/reward decision making by dopaminergic transmission within the basolateral amygdala.
    Larkin JD; Jenni NL; Floresco SB
    Psychopharmacology (Berl); 2016 Jan; 233(1):121-36. PubMed ID: 26432096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rewarding effect of aggression is reduced by nucleus accumbens dopamine receptor antagonism in mice.
    Couppis MH; Kennedy CH
    Psychopharmacology (Berl); 2008 Apr; 197(3):449-56. PubMed ID: 18193405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.